3369 related articles for article (PubMed ID: 16878035)
1. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
[TBL] [Abstract][Full Text] [Related]
5. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.
Kettelhack C; Hönes C; Messinger D; Schlag PM
Br J Surg; 1998 Jan; 85(1):63-7. PubMed ID: 9462386
[TBL] [Abstract][Full Text] [Related]
6. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
8. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
Voils SA; Harpe SH; Brophy GM
Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell transfusions and nosocomial infections in critically ill patients.
Taylor RW; O'Brien J; Trottier SJ; Manganaro L; Cytron M; Lesko MF; Arnzen K; Cappadoro C; Fu M; Plisco MS; Sadaka FG; Veremakis C
Crit Care Med; 2006 Sep; 34(9):2302-8; quiz 2309. PubMed ID: 16849995
[TBL] [Abstract][Full Text] [Related]
10. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
[TBL] [Abstract][Full Text] [Related]
11. The role of erythropoietin therapy in the critically ill.
Corwin HL
Transfus Med Rev; 2006 Jan; 20(1):27-33. PubMed ID: 16373185
[TBL] [Abstract][Full Text] [Related]
12. Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?
Liet JM; Paranon S; Baraton L; Dejode JM; Rozé JC
Pediatr Crit Care Med; 2006 Nov; 7(6):541-4. PubMed ID: 17006380
[TBL] [Abstract][Full Text] [Related]
13. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study.
Chant C; Wilson G; Friedrich JO
Crit Care; 2006; 10(5):R140. PubMed ID: 17002795
[TBL] [Abstract][Full Text] [Related]
14. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry.
Rana R; Afessa B; Keegan MT; Whalen FX; Nuttall GA; Evenson LK; Peters SG; Winters JL; Hubmayr RD; Moore SB; Gajic O;
Crit Care Med; 2006 Jul; 34(7):1892-7. PubMed ID: 16691136
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.
Zilberberg MD; Carter C; Lefebvre P; Raut M; Vekeman F; Duh MS; Shorr AF
Crit Care; 2007; 11(3):R63. PubMed ID: 17553147
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.
Corwin HL; Gettinger A; Rodriguez RM; Pearl RG; Gubler KD; Enny C; Colton T; Corwin MJ
Crit Care Med; 1999 Nov; 27(11):2346-50. PubMed ID: 10579246
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to blood product transfusion in the critically ill: erythropoietin.
Stubbs JR
Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
